Press Releases Apontis Pharma AG Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Real-time Estimate Tradegate Other stock markets 11:46:56 2024-05-08 EDT			5-day change	1st Jan Change
8.66 ^EUR	+7.18%		+1.96%	+78.21%

04-05	Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	MT
03-28	Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apontis Pharma : Earnings Call Q1/24 Presentation	11:42am	PU
APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed	01:34am	EQ
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast	04-05	EQ
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications	04-05	EQ
APONTIS PHARMA expects profitable growth again in 2024	03-28	EQ
Apontis Pharma : Earnings Call 2023 Presentation	03-27	PU
APONTIS PHARMA successfully completes performance and efficiency improvement program	02-06	EQ
APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published	11-09	EQ
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program	11-08	EQ
APONTIS PHARMA confirms preliminary figures – H1 2023 sales and earnings decline	23-08-10	EQ
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024	23-07-31	EQ
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched	23-07-27	EQ
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026	23-07-27	EQ
APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as successor	23-07-10	EQ
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons	23-07-10	EQ
APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of three launches in 2023	23-06-29	EQ
APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills	23-05-09	EQ
APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development partnership with Zentiva Group for another Single Pill with EU-wide intellectual property rights	23-05-08	EQ
DD: APONTIS PHARMA AG: Thomas Milz, buy	23-05-05	EQ
DD: APONTIS PHARMA AG: Silke Reineke, buy	23-05-05	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Apontis Pharma AG Deutsche Boerse AG

Equities

APPH

DE000A3CMGM5

Press Releases

Filters